CoChat

Quantitative home-based assessment of Parkinson’s symptoms: The SENSE-PARK feasibility and usability study

Open access

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; none of the 11 sources its claims cite is checked for support yet.

Abstract

BACKGROUND: Currently, assessment of symptoms associated with Parkinson's disease is mainly performed in the clinic. However, these assessments have limitations because they provide only a snapshot of the condition. METHODS: The feasibility and usability of an objective, continuous and relatively unobtrusive system (SENSE-PARK System), which consists of wearable sensors (three worn during the day and one worn at night), a smartphone-based App, a balance board and computer software, was tested 24/7 over 12 weeks in a study including 22 PD patients. During the first four weeks of the study, patients did not get feedback about their performance, during the last eight weeks they did. The study included seven clinical visits with standardized interviews, and regular phone contact. The primary outcome was the number of drop-outs during the study. As secondary outcomes, the Post-Study System Usability Questionnaire (PSSUQ), score and information obtained from the standardized interviews were used to evaluate the usability of the system. RESULTS: All patients completed the study. The participants rated the usability of the SENSE-PARK System with a mean score of 2.67 (±0.49) on the PSSUQ. The interviews revealed that most participants liked using the system and appreciated that it signaled changes in their health condition. CONCLUSIONS: This 12 week controlled study demonstrates that the acceptance level of PD patients using the SENSE-PARK System as a home-based 24/7 assessment is very good. Particular emphasis should be given to a user-friendly design. Motivation to wear such a system can be increased by providing direct feedback about the individual health condition.

Overview

CoChat Summary

TL;DR

The SENSE-PARK feasibility and usability study found that a home-based 24/7 system of wearable sensors, smartphone app, balance board, and software was acceptable and feasible in 22 Parkinson’s disease patients over 12 weeks, with all participants completing the study. Usability among system users was rated 2.67 ± 0.49 on the PSSUQ (1 best to 7 worst), and most users liked the system and valued feedback on health changes.

Key findings

  • All 22 idiopathic PD patients completed the study; all users and non-users showed willingness to continue from visit 1 to visit 8. Among users, most completed protocol tasks, and only one participant failed to transfer data when asked.
  • Usability was assessed only for system users: mean PSSUQ score 2.67 (±0.49) (1 = best, 7 = worst). Norway users scored slightly better on some items, including efficient task completion, comfort with using the system, and ease of learning.
  • Interviews indicated most participants liked using the system and appreciated that it signaled changes in their health condition. No adverse events were recorded in non-users; however, the paper later reports four adverse events (three definitely related, one possibly related), and Table 2 lists cases including allergy to plastic bracelet, loss of wrist sensor, minor stroke, and broken sensor.

Methods

  • Multi-centre, open-label, feasibility and usability study at three sites (University of Lisbon, Portugal; University of Tübingen, Germany; University of Tromsö, Norway). 22 idiopathic PD patients (14 male, 8 female) were divided into 11 SENSE-PARK System users and 11 non-users; users used the system for 12 weeks and performed clinical assessments every other week, while non-users only completed clinical assessments.
  • The SENSE-PARK System included three daytime wearable sensors and one nighttime sensor, a smartphone app, a Wii Balance Board, and computer software; it collected motor, balance, and cognitive data 24/7. After the first 4 weeks, users received a software version providing feedback. Primary outcome was drop-outs; secondary outcomes included PSSUQ and standardized interviews. Analyses in R 3.0.3 were descriptive for demographics/clinical data, with usability assessed via PSSUQ and feasibility via willingness, completeness, training time, compliance, data transfer, ease of use, and satisfaction.

Limitations

  • The paper states this is a pilot “proof of concept”; there is no evidence yet that the test array improves treatment in clinical practice or that cost-benefit is favorable. It calls for further studies in larger patient populations, including whether the system can detect need for treatment changes and whether country-specific issues affect clinical introduction.
  • Evident from the text: the sample is small (22 total; usability assessed in only 11 users), the assessment period is short (12 weeks), and the study is not designed to test clinical efficacy. The text also contains inconsistencies: the discussion says patients maintained involvement over 16 weeks while the abstract/methods specify 12 weeks, and adverse event reporting is inconsistent (text says four adverse events, while Table 2 lists six cases and non-users are described as having no adverse events).

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12883-015-0343-z

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 From left to right: Inertial sensor unit with housing and wristlet band; Wii balance board; interface software; SENSE-PARK App
Fig. 1 From left to right: Inertial sensor unit with housing and wristlet band; Wii balance board; interface software; SENSE-PARK AppCC BY · PubMed Central
Fig. 2 Study design. V: Visit; PC: Phone Contact; VH: Home visits
Fig. 2 Study design. V: Visit; PC: Phone Contact; VH: Home visitsCC BY · PubMed Central
Fig. 3 a Bar plot showing the frequency of doubts along the study; b Number of tasks preformed; c Number of times the investigator found the recorded data
Fig. 3 a Bar plot showing the frequency of doubts along the study; b Number of tasks preformed; c Number of times the investigator found the recorded dataCC BY · PubMed Central
Fig. 4 Plot showing the mean values of responses for the PSSUQ scale divided by country
Fig. 4 Plot showing the mean values of responses for the PSSUQ scale divided by countryCC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 9 Not checked · 25 Own results and interpretations

5 more claims

Create a free account to see all 34 claims and to verify the 11 references still open.

See all claims — free account
  • It may state two separate claims as one. 20
  • The quote only partly states this claim. 2
  • Probably not a substantial claim. 10

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 21 references

Cited by

  • Technology in Parkinson’s disease: challenges and opportunities

    Espay, A. J., Bonato, P., Nahab, F. B., Maetzler, W., Dean, J. M., Klucken, J., Eskofier, B. M., Merola, A., Horak, F., Lang, A. E., et al. (2016) · Movement Disorders · doi:10.1002/mds.26642 · Cited by 654

    “Preliminary evidence suggests that patient empowerment and their inclusion as active players in the development of research activities may favorably impact compliance.(47) Research is needed to determine the characteristics of wearable systems for long-term monitoring of motor and nonmotor symptoms that would be accep…”
    BackgroundSelf-citation
  • Free‐living monitoring of Parkinson's disease: Lessons from the field

    Del Din, S., Godfrey, A., Mazzà, C., Lord, S., & Rochester, L. (2016) · Movement Disorders · doi:10.1002/mds.26718 · Cited by 370

    “Compliance is high, although in some cases results were influenced by sociocultural aspects that may have positively biased results.(23) In summary, to date there is no fully validated WTCD system for continuous monitoring of patient clinical features.”
    Result
  • Feasibility of large-scale deployment of multiple wearable sensors in Parkinson's disease

    Silva de Lima, A. L., Hahn, T., Evers, L. J. W., de Vries, N. M., Cohen, E., Afek, M., Bataille, L., Daeschler, M., Claes, K., Boroojerdi, B., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0189161 · Cited by 162

    “Compliance, similar to previous studies[31, 32], was calculated as the median percentage of the study period where accelerometer data were collected.”
  • An update on adaptive deep brain stimulation in Parkinson's disease

    Habets, J. G. V., Heijmans, M., Kuijf, M. L., Janssen, M. L. F., Temel, Y., & Kubben, P. L. (2018) · Movement Disorders · doi:10.1002/mds.115 · Cited by 169

  • Moving Parkinson care to the home

    Dorsey, E. R., Vlaanderen, F. P., Engelen, L. J., Kieburtz, K. D., Zhu, W. Y., Biglan, K., Faber, M. J., & Bloem, B. R. (2016) · Movement Disorders · doi:10.1002/mds.26744 · Cited by 163

    “Issues such as feasibility (can patients manage these new devices?), compliance (can patients handle prolonged use of wearable sensors?), and validity (do the devices capture clinically relevant information that inform care?) remain to be addressed, but the initial experience is positive, provided that patients are fu…”
    Background

See all 100

Metadata

Authors
Ferreira, J. J., Godinho, C., Santos, A. T., Domingos, J., Abreu, D., Lobo, R., Gonçalves, N., Barra, M., Larsen, F., Fagerbakke, Ø., Akeren, I., Wangen, H., Serrano, J. A., Weber, P., Thoms, A., Meckler, S., Sollinger, S., van Uem, J., Hobert, M. A., Maier, K. S., Matthew, H., Isaacs, T., Duffen, J., Graessner, H., & Maetzler, W.
Affiliations
  • University of Lisbon (PT)
  • Instituto de Medicina Molecular João Lobo Antunes (PT)
  • University Hospital of North Norway (NO)
  • Hasomed (Germany) (DE)
  • Hahn-Schickard-Gesellschaft für angewandte Forschung (DE)
  • AbilityNet (United Kingdom) (GB)
  • German Center for Neurodegenerative Diseases (DE)
  • Cure Parkinson's Trust (GB)
  • University of Tübingen (DE)
Corresponding author
Ferreira, Joaquim J.
Venue
BMC Neurology
Published
2015-06-10
Volume
15
Issue
1
Pages
89-89
ISSN
1471-2377 (ISSN-L)
OpenAlex
W1587062236
Cited by
96
References
21
Citations by year
2025: 3 · 2024: 11 · 2023: 8 · 2022: 9 · 2021: 15 · 2020: 13 · 2019: 7 · 2018: 9 · 2017: 7 · 2016: 11 · 2015: 3
FWCI
26.63
Type
journal article
Language
en
Open access
Locations
  • BMC Neurology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Multimedialen Archiv und Publikationsserver der Christian-Albrechts-Universität zu Kiel (Christian-Albrechts-Universität zu Kiel) (submittedVersion, cc-by)
  • Repositório Comum (Repositório Científico de Acesso Aberto de Portugal) (submittedVersion, cc-by)
  • Repositório Comum (Repositório Científico de Acesso Aberto de Portugal) (submittedVersion)
  • NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
  • DZNE Pub (submittedVersion, other-oa)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
Funders
European Commission (288557)
Topics
  • Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Balance, Gait, and Falls Prevention
  • Physical Sciences › Computer Science › Computer Vision and Pattern Recognition › Context-Aware Activity Recognition Systems
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
Keywords
Parkinson's disease, wearable sensors, mobile application, balance board, usability, feasibility, patient acceptance
MeSH terms
Aged, Feasibility Studies, Female, Humans, Male, Middle Aged, Parkinson Disease, Patient Acceptance of Health Care, Patient Compliance, Pilot Projects, Multicenter Studies as Topic, Patient Satisfaction, Monitoring, Ambulatory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Quantitative home-based assessment of Parkinson’s symptoms: The SENSE-PARK feasibility and usability study. https://app.cochat.ai/papers/10.1186/s12883-015-0343-z
The paper
Ferreira, J. J., Godinho, C., Santos, A. T., Domingos, J., Abreu, D., Lobo, R., Gonçalves, N., Barra, M., Larsen, F., Fagerbakke, Ø., Akeren, I., Wangen, H., Serrano, J. A., Weber, P., Thoms, A., Meckler, S., Sollinger, S., van Uem, J., Hobert, M. A., . . . Maetzler, W. (2015). Quantitative home-based assessment of Parkinson’s symptoms: The SENSE-PARK feasibility and usability study. BMC Neurology. https://doi.org/10.1186/s12883-015-0343-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.